Disorders of iron metabolism, blood marrow insufficiency or metastases, malnutrition, bleeding at tumor site, catabolism of patients with tumor burden and relative deficiency of erythropoietin all play a role in anemic pathogenesis. The gene discussed is EPO; the disease is neoplasm.